Boule Diagnostics AbOMXSTO: BOUL

BOUL: Revenue fell 12% amid restructuring, but operational improvements and portfolio expansion drive future growth

· Issued by Boule Diagnostics AB

2025 saw a strategic transformation with a new segment structure, cost discipline, and digitalization. Revenue declined 12%, but operational improvements and portfolio expansion position the company for future growth. Key risks include geopolitical instability and regulatory challenges.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from Boule Diagnostics Ab

All Boule Diagnostics Ab news releases